State of the Art Technology
State-of-the-Art Technology at UH Seidman Cancer Center Leads to More Precise Diagnosis and Better Treatments
At University Hospitals Seidman Cancer Center in Cleveland, Ohio we are leading the way in the diagnosis and treatment of cancer with state-of-the-art technology that allows our expert care teams to detect tumors earlier, target cancer cells more precisely and perform complex procedures using minimally invasive techniques.
Offering Some of the Most Advanced Technology in the World
UH Seidman Cancer Center offers technology available at only a few select cancer hospitals in the country and across the globe. Some of the firsts UH Seidman Cancer Center can claim include the following:
- We are the only cancer hospital in the world to house a PET/MRI scanner, which helps physicians better understand disease development by providing them with vital information that other imaging technologies are unable to see. This scanner utilizes positron emission tomography (PET) and magnetic resonance imaging (MRI) technology generate enhanced digital images, enables radiologists to accurately pinpoint cancer locations for more precise treatment.
- We were the first cancer hospital in Ohio to offer CyberKnife®: This technology offers a pain-free nonsurgical technique for patients who have inoperable or surgically complex tumors, have otherwise failed treatment, or who may be looking for an alternative to surgery.
- We are the first cancer hospital in the country to provide an intra-operative MRI Siemens Verio 3.0 Tesla, which allows surgeons to obtain real-time internal images, thus ensuring cancerous tissue is wholly removed before a procedure is complete and reducing the need for a second surgery.
We also offer the latest radiology and radiation equipment for detecting and treating cancer, including:
- Computed tomography (CT ), MRI and PET scanners
- Gamma Knife® Perfexion™ radiosurgery: The most accurate form of stereotactic radiosurgery for the brain
- Itraoperative radiation therapy: Allows the efficiency of radiation delivered directly to the tumor site in an open surgical setting
- Image-guided linear accelerators
Access to Clinical Trials for the Latest Treatment Options
As a part of the National Cancer Institute-designated Case Comprehensive Cancer Center through Case Western Reserve University, UH Seidman Cancer Center’s team of physician-scientists and clinical researchers are actively involved in more that 300 clinical trials that are studying and developing novel procedures, tests, tools and medications.
Our physicians-scientists participate in trials using radiosurgery, photo dynamic therapy and minimally invasive surgery to advance local-regional therapies for cancer. Our leadership position in research provides direct benefits through new treatment options and improved quality of life.
UH Seidman Cancer Center, part of the Case Comprehensive Cancer Center at Case Western Reserve University, is also one of seven cancer centers in the country to have access to a pipeline of new drugs through the National Cancer Institute, offering patients newer and better treatment options.
We continue to participate in early development of FDA-approved drugs for all disease sites. Approximately 20 percent of our patients participate in clinical trials compared to the national average of 3 to 4 percent.